Skip to main content
Top
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

A systematic review of transitions between cigarette and smokeless tobacco product use in the United States

Authors: Jamie Tam, Hannah R Day, Brian L Rostron, Benjamin J Apelberg

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

Smokeless tobacco use is becoming an increasingly important public health issue in the US and may influence cigarette smoking behavior. Systematic information on transitions between smokeless tobacco and cigarette use in the US is limited.

Methods

We conducted a systematic review of published literature on transitions between smokeless tobacco and cigarette use in the US. We searched PubMed, Web of Science and EbscoHost databases for all published articles from January 2000 to March 2014 that presented estimates of transitions in US youth and adult study populations over time between at least one of the following tobacco use states: exclusive cigarette smoking, exclusive smokeless tobacco use, dual use of both products, and use of neither product. We excluded non-English language studies, studies published before 2000, clinical trials, controlled cessation programs, and clinical studies or evaluations of smokeless tobacco cessation programs.

Results

The review identified six studies on US populations published since 2000 with longitudinal data on some or all of the transitions that users can undergo between smokeless tobacco and cigarette use. There was considerable heterogeneity across studies in design and tobacco use definitions. Despite these differences, the existing data indicate that switching behaviors from exclusive smoking to exclusive smokeless tobacco use are limited (adults: 0%-1.4%, adolescents: 0.8%-3.8%) but may be more common from exclusive smokeless tobacco use to exclusive smoking (adults: 0.9%-26.6%, adolescents: 16.6%-25.5%). Among adults, exclusive cigarette smoking was generally stable and consistent (79.7% to 87.6%) over follow-up across studies but less stable in adolescents (46.8%-78.7%). Exclusive smokeless tobacco use was less stable than exclusive cigarette smoking over time (adults: 59.4%-76.6%, adolescents: 26.2%-44.8%).

Conclusion

This review provides published estimates of the proportions of adults and adolescents transitioning between tobacco use categories from the most recently available studies on longitudinal transitions between smokeless tobacco and cigarettes in the US. These data can be used to track tobacco use behaviors and evaluate their effect on public health; however, the data for these studies were generally collected more than a decade ago. Additional research including nationally representative longitudinal estimates using consistent definitions and designs, would improve understanding of current tobacco transition behaviors.
Literature
1.
go back to reference King BA, Dube SR, Tynan MA. Current tobacco use among adults in the United States: findings from the National Adult Tobacco Survey. Am J Public Health. 2012;102:e93–100.CrossRefPubMedPubMedCentral King BA, Dube SR, Tynan MA. Current tobacco use among adults in the United States: findings from the National Adult Tobacco Survey. Am J Public Health. 2012;102:e93–100.CrossRefPubMedPubMedCentral
2.
go back to reference Centers for Disease Control and Prevention. Tobacco product use among middle and high school students - United States, 2011 and 2012. Morb Mortal Wkly Rep. 2013;62:893–7. Centers for Disease Control and Prevention. Tobacco product use among middle and high school students - United States, 2011 and 2012. Morb Mortal Wkly Rep. 2013;62:893–7.
3.
go back to reference Arrazola RA, Kuiper NM, Dube SR. Patterns of current use of tobacco products among u.s. High school students for 2000-2012-findings from the national youth tobacco survey. J Adolesc Health. 2014;54:54–60.CrossRefPubMed Arrazola RA, Kuiper NM, Dube SR. Patterns of current use of tobacco products among u.s. High school students for 2000-2012-findings from the national youth tobacco survey. J Adolesc Health. 2014;54:54–60.CrossRefPubMed
4.
go back to reference US Public Law 111–31, H.R. 1256. 2014. 4-30-2014. US Public Law 111–31, H.R. 1256. 2014. 4-30-2014.
6.
go back to reference Delnevo CD, Wackowski OA, Giovenco DP, Manderski MT, Hrywna M, Ling PM. Examining market trends in the United States smokeless tobacco use: 2005–2011. Tob Control. 2012;23:107–12.CrossRefPubMedPubMedCentral Delnevo CD, Wackowski OA, Giovenco DP, Manderski MT, Hrywna M, Ling PM. Examining market trends in the United States smokeless tobacco use: 2005–2011. Tob Control. 2012;23:107–12.CrossRefPubMedPubMedCentral
7.
go back to reference Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol. 2008;9:667–75.CrossRefPubMed Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol. 2008;9:667–75.CrossRefPubMed
9.
go back to reference Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ. 2009;339:b3060.CrossRefPubMedPubMedCentral Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ. 2009;339:b3060.CrossRefPubMedPubMedCentral
10.
go back to reference Critchley JA, Unal B. Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studies. Eur J Cardiovasc Prev Rehabil. 2004;11:101–12.CrossRefPubMed Critchley JA, Unal B. Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studies. Eur J Cardiovasc Prev Rehabil. 2004;11:101–12.CrossRefPubMed
11.
go back to reference Colilla SA. An epidemiologic review of smokeless tobacco health effects and harm reduction potential. Regul Toxicol Pharmacol. 2010;56:197–211.CrossRefPubMed Colilla SA. An epidemiologic review of smokeless tobacco health effects and harm reduction potential. Regul Toxicol Pharmacol. 2010;56:197–211.CrossRefPubMed
13.
go back to reference Lee PN. The effect on health of switching from cigarettes to snus - a review. Regul Toxicol Pharmacol. 2013;66:1–5.CrossRefPubMed Lee PN. The effect on health of switching from cigarettes to snus - a review. Regul Toxicol Pharmacol. 2013;66:1–5.CrossRefPubMed
14.
go back to reference Lee PN. Health risks related to dual use of cigarettes and snus - A systematic review. Regul Toxicol Pharmacol. 2014;69:125–34.CrossRefPubMed Lee PN. Health risks related to dual use of cigarettes and snus - A systematic review. Regul Toxicol Pharmacol. 2014;69:125–34.CrossRefPubMed
15.
go back to reference Zhu SH, Wang JB, Hartman A, Zhuang Y, Gamst A, Gibson JT, et al. Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results? Tob Control. 2009;18:82–7.CrossRefPubMedPubMedCentral Zhu SH, Wang JB, Hartman A, Zhuang Y, Gamst A, Gibson JT, et al. Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results? Tob Control. 2009;18:82–7.CrossRefPubMedPubMedCentral
16.
go back to reference Wetter DW, McClure JB, de Moor C, Cofta-Gunn L, Cummings S, Cinciripini PM, et al. Concomitant use of cigarettes and smokeless tobacco: prevalence, correlates, and predictors of tobacco cessation. Prev Med. 2002;34:638–48.CrossRefPubMed Wetter DW, McClure JB, de Moor C, Cofta-Gunn L, Cummings S, Cinciripini PM, et al. Concomitant use of cigarettes and smokeless tobacco: prevalence, correlates, and predictors of tobacco cessation. Prev Med. 2002;34:638–48.CrossRefPubMed
17.
go back to reference Haddock CK, Weg MV, DeBon M, Klesges RC, Talcott GW, Lando H, et al. Evidence that smokeless tobacco use is a gateway for smoking initiation in young adult males. Prev Med. 2001;32:262–7.CrossRefPubMed Haddock CK, Weg MV, DeBon M, Klesges RC, Talcott GW, Lando H, et al. Evidence that smokeless tobacco use is a gateway for smoking initiation in young adult males. Prev Med. 2001;32:262–7.CrossRefPubMed
18.
go back to reference O’Hegarty MM, Pederson LL, Asman KJ, Malarcher AM, Mirza SA. Are Adolescent Cigarette Smokers Who Use Smokeless Tobacco More Likely to Continue Smoking in the Future than Cigarette-Only Smokers: Results from Waves I and II of the Adolescent Health Survey. International Scholarly Research Network 2012;304508. O’Hegarty MM, Pederson LL, Asman KJ, Malarcher AM, Mirza SA. Are Adolescent Cigarette Smokers Who Use Smokeless Tobacco More Likely to Continue Smoking in the Future than Cigarette-Only Smokers: Results from Waves I and II of the Adolescent Health Survey. International Scholarly Research Network 2012;304508.
19.
go back to reference Tomar SL. Is use of smokeless tobacco a risk factor for cigarette smoking? The U.S. experience. Nicotine Tob Res. 2003;5:561–9.CrossRefPubMed Tomar SL. Is use of smokeless tobacco a risk factor for cigarette smoking? The U.S. experience. Nicotine Tob Res. 2003;5:561–9.CrossRefPubMed
20.
go back to reference Severson HH, Forrester KK, Biglan A. Use of smokeless tobacco is a risk factor for cigarette smoking. Nicotine Tob Res. 2007;9:1331–7.CrossRefPubMed Severson HH, Forrester KK, Biglan A. Use of smokeless tobacco is a risk factor for cigarette smoking. Nicotine Tob Res. 2007;9:1331–7.CrossRefPubMed
21.
go back to reference Biglan A, Ary DV, Smolkowski K, Duncan T, Black C. A randomised controlled trial of a community intervention to prevent adolescent tobacco use. Tob Control. 2000;9:24–32.CrossRefPubMedPubMedCentral Biglan A, Ary DV, Smolkowski K, Duncan T, Black C. A randomised controlled trial of a community intervention to prevent adolescent tobacco use. Tob Control. 2000;9:24–32.CrossRefPubMedPubMedCentral
22.
go back to reference Mejia AB, Ling PM, Glantz SA. Quantifying the effects of promoting smokeless tobacco as a harm reduction strategy in the USA. Tob Control. 2010;19:297–305.CrossRefPubMedPubMedCentral Mejia AB, Ling PM, Glantz SA. Quantifying the effects of promoting smokeless tobacco as a harm reduction strategy in the USA. Tob Control. 2010;19:297–305.CrossRefPubMedPubMedCentral
23.
go back to reference Bachand AM, Sulsky SI. A dynamic population model for estimating all-cause mortality due to lifetime exposure history. Regul Toxicol Pharmacol. 2013;67:246–51.CrossRefPubMed Bachand AM, Sulsky SI. A dynamic population model for estimating all-cause mortality due to lifetime exposure history. Regul Toxicol Pharmacol. 2013;67:246–51.CrossRefPubMed
Metadata
Title
A systematic review of transitions between cigarette and smokeless tobacco product use in the United States
Authors
Jamie Tam
Hannah R Day
Brian L Rostron
Benjamin J Apelberg
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1594-8

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue